Given that tryptophan is a substrate for SLC6A14, the inhibitor -methyltryptophan (-MT) suppresses the growth of SLC6A14-positive breast cancer, PDAC, and CRC cells but not SLC6A14-negative cells 107,108,109
Red Flags & Side Effects Most people sail through IV therapy with no issues, but side effects can happen
Both platforms also offer migraine treatments
The overview given below is not intended to be comprehensive, but will give some insight into the geographical variation and recent time trends
Diarrhoea is reported in around 30% of users across the STEP trials
The medication's long half-life provides some buffer, and many patients do not experience immediate return of appetite or weight gain after a single missed injection